Supply Chain and Delivery | 7% While clearing the supply-chain bottleneck might be a great catalyst, we allocated only 7% as its challenging to attribute a 1:1 impact to the GLP tailwind for these companies' stock prices, as they are involved in other businesses as well
"Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial"
In response to questions about potential breaches of the law, the regulator said it did not comment on individual cases, but pointed to recently published warnings about unapproved melanotan products used for tanning
Otherwise, the pharmacy history and medication limitation rule it out
Anyone interested in using these medications should ask about the manufacturer and compare their choices with FDA-cleared products, which usually have more data on safety and use
Barrea L, Marzullo P, Muscogiuri G, Di Somma C, Scacchi M, Orio F, Aimaretti G, Colao A, Savastano S